Cytogenetics and clinical features of pediatric myelodysplastic syndrome in Japan
- 27 September 2014
- journal article
- Published by Springer Nature in International Journal of Hematology
- Vol. 100 (5) , 478-484
Abstract
We analyzed the cytogenetics and clinical features of pediatric myelodysplastic syndrome (MDS) in Japan. Data on patients (P < 0.01). However, patients with trisomy 8 had prognoses comparable to those with normal karyotypes. Complex karyotypes were associated with poorer prognoses among RAEB and RAEBt patients. In conclusion, prognosis of pediatric MDS is related to cytogenetics. A more precise diagnosis and classification system is needed for childhood MDS.Keywords
This publication has 28 references indexed in Scilit:
- Complex karyotype newly defined: the strongest prognostic factor in advanced childhood myelodysplastic syndromeBlood, 2010
- Treatment of children with refractory anemia: The Japanese Childhood MDS Study Group trial (MDS99)Pediatric Blood & Cancer, 2009
- Comparison of childhood myelodysplastic syndrome, AML FAB M6 or M7, CCG 2891: Report from the Children's Oncology GroupPediatric Blood & Cancer, 2007
- Therapy-related myelodysplastic syndrome in childhood: A retrospective study of 36 patients in JapanLeukemia Research, 2005
- The International Prognostic Scoring System (IPSS) for childhood myelodysplastic syndrome (MDS) and juvenile myelomonocytic leukemia (JMML)Leukemia, 2004
- CHILDHOOD MYELODYSPLASTIC SYNDROMES IN A BRAZILIAN POPULATIONPediatric Hematology and Oncology, 1999
- Myelodysplastic syndromes in childhood: report of 49 patients from a French multicentre studyBritish Journal of Haematology, 1996
- Myelodysplastic syndrome in a child with constitutional trisomy 8 mosaicism and normal phenotypeCancer Genetics and Cytogenetics, 1995
- Primary myelodysplastic syndrome in children: the clinical experience in 33 casesBritish Journal of Haematology, 1992
- Proposals for the classification of the myelodysplastic syndromesBritish Journal of Haematology, 1982